In recent years it has become increasingly apparent that the phosphoinositide (PI) cycle represents a major second messenger system, comparable in importance to CAMP for actions of hormones, neurotransmitters, and other regulatory molecules. The PI cycle responds to the actions of an agonist at a membrane receptor that, via coupling to a G-protein, triggers the hydrolysis of phosphatidylinositol bisophosphate, resulting in the generation of inositol 1,4,5trisphosphate (IP,) and diacylglycerol (DAG). DAG enhances the activity of protein kinase C (PKC) by rendering it more sensitive to stimulation by Ca*+ (Nishizuka, 1988), while IP, stimulates the release of CaZ+ from endoplasmic reticulum (ER) stores (Berridge, 1987; Berridge and Irvine, 1989) . The Ca2+ released by IP, stimulation activates many calcium-dependent processes. For instance, it enhances the phosphorylation of diverse substrates by PKC. IP, can be further phosphorylated to form inositol 1,3,4,Qetrakisphosphate (IP,), inositol 1,3,4,5,6-pentakisphosphate (IP,), and inositol hexakisphosphate (IP,). These higher inositol phosphates are present in the brain and other tissues in concentrations comparable to those of IP,, and so they may have comparably important functions, which have not been established, however.
Inositol phosphate receptor characterization and isolation
The first attempts to label IP, receptors by ligand binding utilized peripheral tissues such as neutrophils, liver, and adrenal membranes (Baukal et al., 1985; Spat et al., 1986; Guillemette et al., 1987) . The relatively low levels of specific IP, binding in these tissues precluded their direct biochemical characterization. By utilizing autoradiography to detect receptor bound 3H-IP,, much higher levels of IP, receptors were found in the CNS, where they are present at a very high density in the Purkinje cells of the cerebellum, the tissue source presently utilized for most biochemical studies of IP, receptors (Worley et al., 1987a (Worley et al., , 1989 . The inositol phosphate specificity of the cerebellar IP, receptor is essentially the same as that of peripheral tissues (Berridge, 1987; Berridge and Irvine, 1989) .
Several properties of IP, receptors appear to reflect their physiologically important regulatory function. For instance, physiologic levels of Ca2+ inhibit IP, binding to its receptor with an IC,, of about 300 nM (Worley et al., 1987b; Danoff et al., 1988) . This finding implies that CaZ+ released by IP, feeds back to inhibit further stimulation of Ca*+ release by IP,. Increases in intracellular pH from 7.5 to 8.5 cause a tripling in IP, binding to its receptor (Worley et al., 1987b) . Increases in intracellular pH also augment the ability of IP, to release Ca2+ which presumably reflects the effect of pH on binding of IP, to its receptor.
The very high density of IP, receptors present in the cerebellum facilitated purification of the receptor to apparent homogeneity (Supattapone et al., 1988b) . The potent enhancement by heparin of IP, binding to its receptor (Worley et al., 1987b) and of Ca2+ release (Hill et al., 1987; Ghosh et al., 1988 ; Guille-l lnositol Phosphate Receptors mette et al., 1989; allowed the purification of the IP, receptor on heparin-agarose affinity columns. A second purification step resorted to concanavalin-A Sepharose chromatography, which took advantage ofthe glycosylation of the IP, receptor. Together, these purification steps allowed a thousandfold purification of the receptor. Meanwhile, the same degree of purification can be achieved also by use of an IP, affinity column (Prestwich et al., 199 1) . When analyzed by PAGE, the purified IP, receptor protein moved as a single 260 kDa band. However, the molecular weight of the native receptor is about 1000 kDa, reflecting a homotetramer (Supattapone et al., 1988b) structure. This structure has been confirmed recently by chemical cross-linking studies (Maeda et al., 199 1) . The release of Ca2+ stimulation by IP, may be positively cooperative (Meyer et al., 1988 , suggesting that the four subunits interact such that activation of one subunit increases the probability that another subunit will be activated. However, 3H-IP, binding to the pure receptor shows no evidence of cooperativity, with a Hill coefficient of approximately unity (Supattapone et al., 1988b) .
The stimulation by Ca2+ of IP, binding to its receptor largely disappears with purification of the receptor. In crude detergentsolubilized receptor preparations, as well as in intact membranes, Ca2+ in the 100-300 nM range inhibits IP, binding, while Ca2+ has no influence on IP, binding to the purified receptor protein at a thousandfold higher concentration (Supattapone et al., 1988b) . Adding detergent-solubilized brain extracts to purified IP, receptors restores the ability of Ca*+ to inhibit IP, binding, indicating that a Ca*+-binding protein, designated calmedin, confers on Ca*+ the ability to influence IP, binding (Danoff et al., 1988) . Recently, calmedin has been isolated by taking advantage of its adhesion to the IP, receptor so that under appropriate circumstances calmedin copurifies with the IP, receptor on an IP, affinity chromatography column (J. Steiner and S. H. Snyder, unpublished observations). Purified calmedin is a monomer with a molecular weight of about 15 kDa. In the presence of nanomolar concentrations of calmedin, Ca2+ substantially inhibits IP, receptor binding. Calmedin levels in the brain do not parallel the high density of the IP, receptor in cerebellum, suggesting that calmedin may influence other systems besides the IP, receptor. Overall, calmedin comprises about 1% of membrane protein in the brain, similar to tissue levels of calmodulin.
IP, receptors have also been purified to homogeneity from the aorta ) and the vas deferens (Mourey et al., 1990) revealing properties closely similar to those of IP, receptors in the brain (Marks et al., 1990) . However, in the vas deferens Ca*+ does not inhibit IP, binding to its receptor (Mourey et al., 1990) , as it does not inhibit IP, binding in neutrophils, liver cells, and adrenal membranes (Baukal et al., 1985; Spat et al., 1986; Guillemette et al., 1987) . Experiments in which partially purified calmedin is mixed with purified IP, receptors from cerebellar and vas deferens tissue indicate that the IP, receptor of the vas deferens can respond to calmedin, so its lack of response to Ca2+ in situ reflects the absence of calmedin protein in that tissue (Mourey et al., 1990) .
Purified IP, receptors can be phosphorylated by CAMP-dependent protein kinase (PKA) (Supattapone et al., 1988a; Ferris et al., 199 1 b) , PKC (Ferris et al., 199 1 b) , and Ca2+/calmodulindependent protein kinase (CAM-K-II) (Ferris et al., 1991b) . Phosphorylation by any one of these enzymes proceeds stoichiometrically with one molecule of phosphate incorporated per receptor subunit. Phosphorylation by the three enzymes is additive, indicating that they act at different sites. Phosphopeptide maps and phosphoamino acid determination show that, while all three enzymes phosphorylate serine residues, they phosphorylate residues in different domains of the polypeptide chain (Ferris et al., 1991b) . Isolation and direct sequencing of the peptides phosphorylated by PKA reveal that two serine residues, namely 1589 and 1755, are phosphorylated (Ferris et al., 199 la) . Serine 1755 is phosphorylated at low concentrations of PKA, while much higher concentrations of PKA are needed to phosphorylate serine 1589.
We have found recently that IP, receptors can autophosphorylate (Ferris et al., 1992a) . This autophosphorylation is magnesium dependent and reaches a final stoichiometry of 0.3-0.4 mol 32P/mol IP, receptor at 4°C; possibly only a subpopulation of the receptors have this activity. Attribution of this phosphorylation to contaminating kinases is ruled out by several lines of evidence, including renaturation experiments in which autophosphorylation of the 260 kDa IP, receptor is observed on nitrocellulose membranes following SDS-PAGE (Ferris et al., 1992a) . Additionally, the IP, receptor phosphorylates a synthetic peptide substrate, showing that the IP, receptor possesses protein kinase activity.
How can phoshorylation of the IP, receptor regulate its function? In cerebellar cell membranes, receptor phosphorylation by PKA decreases the potency of IP, to release Ca2+ (Supattapone et al., 1988a) . Since PKA phosphorylation also stimulates the Ca2+ pump, total ER Ca*+ levels are increased so that the absolute amount of Ca*+ released by IP, is enhanced by PKA phosphorylation (Supattapone et al., 1988a) . Recent studies indicate that CAMP-dependent hormones increase IP,-induced release of Ca2+ in liver cells (Burgess et al., 199 1) . It is conceivable that phosphorylation of the IP, receptor by PKC and CAM-K-II provides feedback regulation of the PI cycle following the generation of DAG, which stimulates the action of PKC, and the release of CaZ+ by IP,, which can activate both PKC and Cam-K-II. A cerebellar-specific form of CAM-K-II is highly concentrated in Purkinje cells (Ouimet et al., 1984; Fukunaga et al., 1988; Walaas et al., 1988) and has a similar subcellular localization as the IP, receptor.
The biological function of IP,, IP,, and IP, has not yet been identified despite their levels in the brain being as high as those of IP,. Some studies suggest a role for IP, in regulating the movement of Ca2+ into the cell and/or in maintaining levels of IP,-sensitive Ca2+ pools (Morris et al., 1987; Irvine, 1989; Cullen et al., 1990) . IP, and IP, can increase CaZ+ accumulation (Nicoletti et al., 1989) and decrease blood pressure, heart rate (Vallejo et al., 1987; Barraco et al., 1989) , and respiratory rate (Barraco et al., 1989) . However, there is no evidence indicating whether any of these effects represent normal roles for these substances. Characterizing and localizing receptor proteins for these higher inositol phosphates might clarify their functions. IP, binding sites have been identified in brain cell membranes (Theibert et al., 1987; Donie and Reiser, 1989) , and IP, binding sites have also been characterized (Hawkins et al., 1990) . Highaffinity IP,-and IP,/IP,-binding proteins have recently been isolated from the brain (Theibert et al., 199 l) , which possess selectivity and high affinity for their respective ligands. The putative IP, receptor binds IP, with a KD of about 3 nM, while the putative IP,/IP, receptor binds IP, and IP, with a KD of about 6-12 nM. The putative IP,/IP, receptor comprises two 115 and 105 kDa doublets and a 50 kDa singlet. Tryptic peptides from the 105 kDa doublet have been sequenced recently, revealing that the IP, receptor complex is identical to the clathrinassociated assembly protein AP-2 (A. B. Theibert, S. Voglmaier, C. D. Ferris, J. Keen, and S. H. Snyder, unpublished observations). Three prominent IP, receptor subunits of molecular weight about 182, 174, and 84 kDa can be distinguished. Another IP, receptor protein has been isolated independently with similar properties except that it is of lower molecular weight (Donie and Reiser, 199 1) . This difference may reflect proteolytic cleavage of the latter isolate. To ascertain which subunits of the IP, and IP,/IP, receptor proteins carry recognition sites for their ligands, a radiolabeled photoaffinity ligand was employed, permitting analysis of the pH dependence and other properties of these proteins and their subunits (Theibert et al., 1992) . The inositol phosphate binding specificity, pH dependence, and influence of Ca2+ were found to be identical for the 105 and 115 kDa IP, proteins. By contrast, the IP, receptor subunits differ in various respects. The pH dependence for ligand binding by the 174 and 182 kDa proteins is similar, with an optimum at about pH 7, while the 85 kDa protein displays substantial binding at lower pH levels, similar to the IP, receptor protein isolated by Donie and Reiser (199 1) . Ca*+ markedly enhances IP, binding to the 182 and 174 kDa proteins, unlike the marked Ca2+ stimulation of binding observed for the 84 kDa protein.
Reconstitution of IP,-activated Ca2+ channels and their regulation
Does the IP,-binding protein also contain the Ca2+ channel that responds to IP,, or is the Ca2+ channel a distinct protein? To address this question, experiments were carried out in lipid vesicles containing only IP, receptor protein in the reconstituted membrane. This permitted measurement of the IP, influence on @Ca2+ release as well as )H-IP, binding in the same vesicles. In such vesicles, IP, was found to stimulate Ca*+ release (Ferris et al., 1989) . The relative potencies of IP, and other inositol phosphates to influence Ca2+ release correspond closely with their affinities for IP, binding sites. Moreover, heparin, a known IP, antagonist, blocks the actions of IP, on Ca2+ release in the reconstituted system. These experiments established that the purified IP,-binding protein contains both the IP, recognition site and the Ca*+ channel (Ferris et al., 1989) .
Use of reconstituted vesicles containing IP, receptors has permitted demonstration of an allosteric regulation of the receptor by adenine nucleotides (Ferris et al., 1990) . At concentrations between 1 and 10 PM, ATP markedly and cooperatively enhances the ability of IP, to stimulate Ca2+ release. This effect is biphasic, since the enhancing effects on IP,-stimulated Ca2+ release diminish between 0.1 and 1 mM until, at the physiological concentration of 1 mM, ATP no longer enhances IP,-stimulated Ca2+ release at all. This enhancement by ATP is readily distinguished from phosphorylation by use of nonhydrolyzable ATP analogs and is specific for ATP, in comparison with other adenine or guanine nucleotides. It is mediated via a high-affinity ATP recognition site on the IP, receptor, which can be labeled by its binding of 32P-ATP or 35S-ADP-/3-S (Ferris et al., 1990) or by its reaction with an azido derivative of ATP (Maeda et al., 199 1) . The predicted amino acid sequence of the cerebellar IP, receptor contains two possible consensus sequences (GXGXXG) for ATP binding at amino acid residues 1773 and 2016 (Furuichi et al., 1989) .
How might ATP influence the action of IP,? At physiological concentrations (about 1 mM) of ATP, one would expect no obvious influence. However, once IP, stimulates Ca2+ release, the Ca2+-dependent ATPase would be activated to replenish the Ca*+ stores, which can deplete ATP in the vicinity of the IP, receptor. ATP bound with low affinity will then dissociate, and IP,-stimulated Ca2+ release would be augmented in feedforward manner. If ATP levels fall even further, then the ATP bound with high affinity would dissociate, and IP,-stimulated release of Cal+ would diminish, perhaps protecting the cells from noxious Ca2+ concentrations. This model might contribute to the precipitous, spikelike changes in intracellular Ca2+ concentrations associated with Ca2+ oscillations (Smith et al., 1986; Berridge, 1990; Petersen and Wakui, 1990; Meyer and Stryer, 199 1) and help account for the marked cooperativity of IP,-induced Ca2+ release (Meyer et al., 1988 . A similar augmentation of Ca*+ release induced by ATP in reconstituted IP, receptors in planar lipid bilayers has been reported (Maeda et al., 199 1) . ATP also enhances IP, stimulation of Ca2+ channels in crude preparations of ER from the aorta (Ferris et al., 1989 ) and permeabilized cells (Smith et al., 1985) .
In permeabilized pancreatic acinar cells, IP,-stimulated Ca2+ release is a noncontinuous process, such that submaximal concentrations of IP, release submaximal portions of IP,-sensitive Ca2+ stores (Muallem et al., 1989) even under conditions where the IP, is not degraded. This process was described as "quantal" since subfractions of IP,-sensitive Ca2+ stores are activated by IP,. In permeabilized basophils, described the same phenomenon as "incremental" release. Sequential additions of IP, evoke a transient release of Ca2+, monitored with Ca*+-sensitive dyes, such that the final free Ca2+ level for two sequential IP, applications is the same as a single application of the sum . Incremental stimulation of Ca2+ release by IP, could be attributable to many factors. The quanta1 Ca2+ release in purified, reconstituted IP, receptors indicates that the phenomenon is a fundamental property of the IP, receptor (Ferris et al., 1992b) . Submaximal concentrations of IP, fail to activate all of the Ca2+ channels in the reconstituted system (Ferris et al., 1992b) . Moreover, successive additions of IP, provide an arithmetic increase in Ca2+ release over the range of 10-200 nM IP, (Fig. 1) (Ferris et al., 1992b) . Since Ca2+ signaling in cells is known to be spatially and temporally complex (Alkon and Rasmussen, 1988) , involving Ca*+ oscillations and waves (Berridge, 1990; Meyer and Stryer, 199 l) , it is likely that the sequential release properties of the IP, receptor are critical for this precise subcellular regulation of Ca2+ levels in cells.
Molecularly cloned IP3 receptors in multiple forms
The first cloning of the IP, receptor gene arose from efforts to characterize a cerebellar-specific protein designated P-400 (Furuichi et al., 1989) , originally identified as a 400 kDa cerebellar protein localized to Purkinje cells (Mallet et al., 1976) . The characteristics of P-400 (Mikoshiba and Changeux, 1978; Mikoshiba et al., 1979; Maeda et al., 1990) were recognized to be those of the previously isolated IP, receptor (Supattapone et al., 1988b) . Based on the partial sequence of the cDNA of a Purkinje cell-specific protein (Nordquist et al., 1988) antibodies were raised, and resultant immunohistochemical maps revealed that the protein encoded in the cloned P-400 gene was the IP, receptor (Mignery et al., 1989 (Mignery et al., , 1990 . The human IP, receptor was cloned and sequenced from brain libraries (Ross et al., 199 1) . Comprising more than 2700 amino acid residues, the IP, receptor is one of the largest proteins to have been cloned and Figure I . Incremental activation of IP, channels in reconstituted IP, receptor by successive additions of IP,. IP,-induced Wa2+ release was measured as previously described (Feniset al., 1989) . In this preparation, IP, activates Ca2+ channels, which allows the rapid equilibration of 4sCa*+ into vesicles with activated channels in the absence of an actual Ca2+ concentration gradient. Specific cpm refers to the difference between the presence and absence of IP,. Addition of 50 nM IP, to vesicles following 10 set incubation with 50 nM IP, results in enhanced Wa2+ entry to the same level as an initial addition of 100 nM IP,. Likewise, successive 10 set incubations with final IP, concentrations of 50 nM, 100 nM, and 200 nM result in quantitative detection of changes in IP, concentration. Thus, unlike other known ligand activated ion channels which either desensitize (e.g., the nicotinic ACh receptor) or allow continuous ion transport, the IP, receptor exhibits quanta1 release properties. Adapted from Ferris et al. (1992b) .
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-1 Figure 2 . Topology of the IP, receptor. The IP, receptor is a large transmembrane protein with eight hydrophobic putative transmembrane domains at the carboxyl terminus (hatched), a domain of 300-400 amino acid residues at the amino terminus that are sufficient for minimal ligand binding (Mignery and Sudhof, 1990) , and a large hydrophobic and cytosolic coupling domain between wh'ich are regulatory sites for phosphorylation, ATP binding, and alternative splicing in the mRNA. In the binding and coupling domains, known alternative splicing sites are shaded. The putative sites for ligand (ZPJ and AZ?) binding are labeled, as are sites known to be phosphorylated by PKA (P, Ferris et al., 199 la). The sites phosphorylated by PKC and CAM-K-II (Ferris et al., 199 1 b) are not yet known.
sequenced. It is highly conserved among the mammals, as the sequences in rodents and humans differ by less than 10% and only by 1% in rat and mouse. Several very similar molecular models for the IP, receptor have been suggested. A consensual model (Fig. 2) of an individual subunit comprises eight transmembrane domains located at the carboxy terminus of the molecule, with both the amino and carboxy termini on the cytoplasmic surface. Among the eight transmembrane domains, the first four are flanked by net positive charges and the last four by net negative charges (Mignery and . The last four transmembrane domains show the closest homology with the ryanodine receptor (Furuichi et al., 1989; Mignery et al., 1989 Mignery et al., , 1990 , the Ca*+ -stimulated Ca*+ release channel of muscle, and so are likely to comprise the Ca2+-permeable pore.
Mutagenesis studies suggest that the IP, binding site lies in the amino-terminal 400 amino acid residue since receptors with this domain deleted fail to bind IP, (Mignery and Sudhof, 1990; Miyawaki et al., 199 1) . Moreover, truncated forms of the receptor retaining only the N-terminal quarter of the molecule provide soluble peptides that are monomeric but retain IP,-binding capacity (Mignery and Sudhof, 1990; Miyawaki et al., 199 1) . The N-terminal peptide binds IP, with substantially less affinity than does the full protein, so the overall conformation of the intact protein may be important for physiologic IP, binding. Because the IP, binding site is at the extreme N-terminal part ofthe protein, with the putative Ca2+ channel at the extreme C-terminal, IP, binding must elicit a conformational change over a span of virtually 1400 amino acid residues. This fits with findings that a substantial decrease in apparent molecular weight on gel filtration occurs consequent to IP, binding (Mignery and Sudhof, 1990) . Both sites at which PKA catalyzes serine phosphorylation (Ferris et al., 199la) , as well as the ATP consensus binding sites (Ferris and Snyder, 199 1) , are located in the "coupling region" between domains for IP, binding and the Ca2+ channel, where these regulatory sites may affect the ability of IP, binding to activate the Ca2+ channel.
The evolutionary conservation of the primary structure of the IP, receptor suggests that there might be only a single type of IP, receptor. However, multiple forms of IP, receptors derived by alternative mRNA splicing have been observed (Mignery et al., 1990; Danoff et al., 1991; Nakagawa et al., 1991) . One of these forms has been found in rats and mice, with a deletion of 15 amino acids close to the N-terminus (Mignery et al., 1990; Nakagawa et al., 199 1) . Alternatively spliced forms with a deletion of 40 amino acids in the N-terminal third of the molecule, but not as close to the N-terminus as the 15 amino acid deletion, have also been observed (Danoff et al., 1991; Nakagawa et al., 199 1) . Several forms of the receptor with different portions of the 40 amino acid sequence deleted have been detected, suggesting that the 40 amino acids derive from two separate exons (Nakagawa et al., 199 1) . By use of the PCR to monitor relative levels of the receptor with and without the 40 amino acid deletion, it was observed that the long form is exclusively neuronal while the short form appears to be predominantly in non-neuronal tissues (Danoff et al., 199 l) , although the "nonneuronal" form has also been detected in the spinal cord (Nakagawa et al., 199 1) . Substantial differences in levels of the alternatively spliced form of the receptor occur throughout the brain (Nakagawa et al., 199 1) For instance, the form with the 15 amino acid deletion accounts for 75-85% of IP, receptors in the spinal cord and cerebellum but only for 12% of receptors in the cerebral cortex. The proportion of receptors with different extents of loss of the 40 amino acid sequence varies substantially in mouse brain regions as well (Nakagawa et al., 1991) . While all peripheral tissues lack the 40 amino acid sequence, the presence or absence of the 15 amino acid sequence varies substantially among different peripheral organs.
The 40 amino acids deleted in the non-neuronal form lie between two serines at positions 1589 and 1756, which are phosphorylated by PKA (Ferris et al., 199 la) . To examine the influence of the deletion upon phosphorylation, we compared phosphorylation by PKA of the neuronal (cerebellum) and nonneuronal (vas deferens) receptors. While both are stoichiometrically phosphorylated by PKA, the pattern of phosphorylation differs. The brain receptor is preferentially phosphorylated on serine 1756, while the vas deferens receptor is phosphorylated on serine 1589. The 40 amino acid sequence also lies in the area of two consensus sequences for ATP binding, and removal of the 40 amino acid sequence creates a new consensus sequence for ATP binding (Ferris and Snyder, 199 1) .
Evidence has recently been obtained for the existence of other members of the IP, receptor family derived from distinct genes (Ross et al., 1991; Sudhof et al., 1991) . These other putative members of the IP, receptor group are less abundant in brain than the "parent" IP, receptor, and their functions are unclear. The most striking "cousin" of the IP, receptor is the ryanodine receptor (Furuichi et al., 1989; Mignery et al., 1989; Takeshima et al., 1989) . Ryanodine is an alkaloid that binds to a protein that is responsible for Ca 2+-induced Ca2+ release (CICR) from the sarcoplasmic reticulum of striated muscle as a key component of excitation<ontraction coupling (Endo, 1977; Fleischer and Inui, 1989) . Thus, both IP, and ryanodine receptors have Ca*+ channels to promote release of intracellular Ca2+, with the ligand for one being IP, and for the other being CaZ+ itself. Ryanodine and IP, receptors are both large homotetrameric proteins that, when examined under the electron microscope, display fourfold symmetry, with the IP, receptor having forms that appear more mobile than the ryanodine receptor. ATP directly induces Ca2+ release at the ryanodine receptor, whereas at the IP, receptor, ATP enhances the stimulation ofCa2+ release by IP,. While IP, receptors are concentrated in the brain and smooth muscle, ryanodine receptors are at their highest levels in skeletal and cardiac muscle, with much lower levels in smooth muscle and brain. A limited capacity to bind 3H-ryanodine in the brain has been reported (McPherson and Campbell, 1990) , and high-resolution immunohistochemistry has revealed both ryanodine and IP, receptors within the same Purkinje cells in the cerebellum (Ellisman et al., 1990) .
Localization of IP3 and ryanodine receptors in the brain in relation to Ca2+ pools IP, receptors have been localized by autoradiography (Worley et al., 1987a (Worley et al., , 1989 and immunohistochemistry (Ross et al., 1989) and their mRNA has been detected by in situ hybridization with cloned DNA probes (C. A. Ross, C. Glatt, T. Dawson, and S. H. Snyder, unpublished observations). IP, receptors are at their highest density in Purkinje cells of the cerebellum and at their second highest density in the hippocampus, especially in the CA1 region. Receptors have been observed throughout the processes of neurons, with substantial densities being present in terminals of Purkinje cells in the deep nuclei of the cerebellum. In the retina, IP, receptors are at high density in presynaptic nerve terminals of photoreceptors and bipolar cells, as well as in synaptic specializations ofamacrine cells (Peng et al., 199 1) . The association of these receptors with nerve terminals may reflect a role for them in neurotransmitter release, perhaps modulating the influx of Ca*+ through voltage-gated channels that trigger exocytosis of synaptic vesicles. The first studies of IP,-stimulated release of Ca2+ indicated a nonmitochondrial source, which might reflect ER (Streb et al., 1983) . Electron microscopic immunohistochemistry (Mignery et al., 1989; Ross et al., 1989; Otsu et al., 1990; Satoh et al., 1990) confirms an association of IP, receptors with subcomponents of the ER. Both rough and smooth ER are labeled, but with considerably heterogeneous distribution: some elements that show high densities of the receptor label may lie adjacent to morphologically similar but unlabeled elements. In some studies on Purkinje cells, substantial densities of receptor were evident in the ER close to the nuclear membrane and in the nuclear membrane itself (Ross et al., 1989; Satoh et al., 1990) . A role for IP, in nuclear function is further strengthened by observations of nuclear ATP-dependent Ca2+ uptake (Nicotera et al., 1989 ) IP,-stimulated release of Ca2+ (Malviya et al., 1990; Nicotera et al., 1990) , as well as IP, binding (Malviya et al., 1990) in liver nuclei. Cocco et al. (1987) reported polyphosphoinositide synthesis in nuclei of erythroleukemia cells with changes during differentiation.
Immunohistochemical studies of IP, localization in Purkinje cells in cerebellum have failed to detect its presence in mitochondria, Golgi cistemae, or the plasma membrane. However, IP,-activated Ca2+ channels may be present in plasma membranes of lymphocytes (Kuno and Gardner, 1987) . IP, activation of dihydropyridine-sensitive Ca2+ channels has also been detected in preparations of skeletal muscle transverse tubules, which presumably represent plasma membrane channels (Vilven and Coronado, 1988) . Direct evidence has recently been obtained for the existence of IP, receptors in the plasma membrane of olfactory cilia and lymphocytes. Immunohistochemical studies resorting to confocal microscopy reveal a selective association of IP, receptors with olfactory cilia, which lack ER (A. Cunningham, G. Ronnett, R. Reed, and S. H. Snyder, unpublished observations). Moreover, IP, receptors are selectively localized in the plasma membrane of intact Jurkat T lymphocytes under conditions in which the antibody does not penetrate into cells (A. Khan, J. Steiner, and S. H. Snyder, unpublished observations). Moreover, in these cells capping induced by concanavalin A is associated with a concentration of IP, receptor at one pole of the cell, a behavior manifested only by plasma membrane proteins.
IP, receptors in brain slices colocalize with IP,-sensitive Ca2+ pools in the ER labeled with 45Ca2+ in the presence of ATP . The ER stores of Ca2+ labeled in this way display discrete localizations. IP, can stimulate the release of most of the Ca2+ from some brain regions, while other brain regions are relatively resistant to the effects of IP,. Recently, it has been possible to identify Ca 2+-sensitive Ca2+ stores in these preparations (A. Verma, Hirsch, and S. H. Snyder, unpublished observations). In both brain ER and slices, Ca2+ accumulation increases with increasing concentrations of added CaZ+, but then begins to decrease. The decline in accumulated Ca*+ reflects CICR, since the decline is prevented by local anesthetics such as tetracaine and Mg2+, which block CICR. Moreover, this decline is accentuated by caffeine and ATP, which enhance CICR. CaZ+ release stimulated by IP, occurs at lower free Ca*+ concentrations than the CICR process. Thus, as IP, induces release of Ca2+ to provide concentrations greater than 0.5 KM, the released Ca2+ inhibits further actions of IP, and also triggers initiation of the CICR process. The coordinated effects of IP, and CICR on Ca*+ release provide an enhancement of Ca2+ release that may influence Ca2+ oscillations.
IP,-sensitive and CICR pools of Ca2+ are differentially localized. For instance, in the hippocampus CA1 is enriched in the IP, pool, while CA3 has higher densities of CICR. The corpus striatum is enriched in IP,-stimulated Ca2+ channels, while the closely adjacent medial septum has higher densities of CICR. Cerebellar Purkinje cells are greatly enriched in the IP, pool, while the CICR pool predominates in the olfactory bulb. It will be a challenging task to differentiate physiological functions associated with IP, and CICR, respectively.
